Claritev (CTEV)
Helps payers manage medical claims costs through networks, analytics, and payment integrity.
Something off on this page? Send us feedback.
Serves health plans, ASO platforms, and administrators with claims intelligence, network access, payment integrity, and analytics. Operations are concentrated in the U.S., with payer relationships and out-of-network reimbursement rules shaping demand.
Provides claims-cost management tools for payer clients, administrative-services platforms, and third-party administrators. Its solution lines are Claims Intelligence Solutions, Network Solutions, Payment and Revenue Integrity Solutions, and Data and Analytics Solutions, with data and analytics currently reported inside claims intelligence.
Operations are concentrated in the U.S., while a partnership began its first international expansion in the Middle East and North Africa. The platform combines proprietary network access, pricing algorithms, clinical review, and analytics to help clients handle out-of-network reimbursement, claim review, plan design, and provider-network decisions.
The model depends on large payer relationships, access to protected health information, HIPAA compliance, and rules governing out-of-network products. Active reimbursement litigation, debt-service needs, and reported internal-control weaknesses remain structural constraints.
Company facts
Target rangeAs of Sep 2, 2026
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Barclays | Reiterate | Overweight | $28 | $40 | |
| Aug 12, 2026 | Piper Sandler | Reiterate | Overweight | $61 | $73 | |
| Aug 10, 2026 | Canaccord Genuity | Reiterate | Buy | $37 | $43 | |
| Jul 21, 2026 | Canaccord Genuity | Reiterate | Buy | $37 | ||
| Jun 3, 2026 | Piper Sandler | Target | $61 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $14.4M · Total debt $4.62B · Total assets $4.76B · Shareholders' equity −$294.6M
- Revenue
- $257.5M
- Operating income
- $23.4M
- Net income
- −$59.2M
No dividends on record.
| Institutions99 holders · as of Mar 31, 2026 | 83.52% | 14.15M shares | |
| Insiders18 holders · as of Aug 31, 2026 | 12.10% | 2.05M shares | |
| Otherremainder | 4.38% | 742.3K shares |
16.95M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
H&F Corporate Investors VIII, Ltd.Institution | 22.94% | 3.89M | 13Fas of Mar 31, 2026 |
Ares Management LLCInstitution | 10.99% | 1.86M | 13Fas of Mar 31, 2026 |
Arini Capital Management LtdInstitution | 9.06% | 1.53M | 13Fas of Mar 31, 2026 |
Public Investment FundInstitution | 7.56% | 1.28M | 13Fas of Mar 31, 2026 |
Beach Point Capital Management LPInstitution | 4.69% | 795,346 | 13Fas of Mar 31, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 28, 2026 | Travis Dalton | director, officer: Pres., CEO & Executive Chair | +1,950 | $38.48 |
| Aug 27, 2026 | Travis Dalton | director, officer: Pres., CEO & Executive Chair | +4,500 | $38.81 |
| Aug 14, 2026 | Tiffani Misencik | officer: SVP, Chief Growth Officer | −8,850 | $40.07 |
| Aug 10, 2026 | William B. Mintz | officer: SVP, Chief Strategy Officer | −8,431 | $34.24 |
| Jun 9, 2026 | Nutter Carol | officer: SVP, Chief People Officer | +875 | $28.41 |
- UnitedHealth Group
Broadest overlap in out-of-network, payment integrity, and analytics
- CVS Health
Public parent of Aetna First Health, a network-access alternative
- Conduent
Direct payment-integrity peer for health-plan claim recovery
- Solventum
Former 3M health IT unit overlapping in reimbursement accuracy
- Alight
Benefits analytics peer focused on employer health-plan decisions
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Claritev | $40.00 | −0.57% | $685.8M | — | — | 0.7 | +6.6% |
| UnitedHealth Group | $399.46 | −0.06% | $362.95B | 25.7 | 18.7 | 0.8 | +0.4% |
| CVS Health | $97.23 | −0.01% | $124.06B | 25.7 | 12.0 | 0.3 | +7.3% |
| Conduent | $1.89 | +5.00% | $293.1M | — | — | 0.1 | −29.7% |
| Solventum | $91.90 | −0.01% | $15.91B | 11.2 | 13.6 | 1.9 | +2.2% |
| Alight | $14.16 | +0.07% | $373.0M | — | 3.1 | 0.2 | −3.2% |
| Median | 25.7 | 12.8 | 0.3 | +0.4% |